Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap

Molecular Therapy

Volumn 6, Issue 4, 2002, Pages 510-518

  Wustner, Jason T ^a   Arnold, Susan ^a   Lock, Martin ^a   Richardson, James C ^a   Himes, Vaughn B ^a   Kurtzman, Gary ^a   Peluso, Richard W ^a  

^a Targeted Genetics Corporation   (United States)

Author keywords

AAV5; Herpes simplex virus; Vector production

Indexed keywords

CAP PROTEIN; DNA; HELICASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPATHOLOGY; GENE CONSTRUCT; GENE EXPRESSION; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; PLASMID; PROMOTER REGION; PROTEIN LOCALIZATION; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TYPING;

ADENO-ASSOCIATED VIRUS; HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0036799947     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0695     Document Type: Article

References (27)

1. Carter, B. J. (2000). Adeno-associated viruses as gene transfer vehicles. Contrib. Microbiol. 4: 85-106.
2. Muzyczka, N., and Berns, K. I. (2001). Parvoviridae: The viruses and their replication. In Fields virology, fourth edition (D. M. Knipe and P. M. Howley, Eds.), pp. 2327-2359. Lippincott William and Wilkins, Philadelphia.
3. Zabner, J., et al. (2000). Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74: 3852-3858.
4. Davidson, B. L., et al. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad Sci. USA 97: 3428-3432.
5. Chao, H., et al. (2000). Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther. 2: 619-623, doi:10.1006/mthe.2000.0219.
6. Hildinger, M., et al. (2001). Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75: 6199-6203.
7. Duan, D., Yan, Z., Yue, Y., Ding, W., and Engelhardt, J. F. (2001). Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation. J. Virol. 75: 7662-7671.
8. Rabinowitz, J. E., et al. (2002). Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76: 791-801.
9. Buller, R. M. L. (1981). Herpes simplex virus types 1 and 2 completely help adeno-associated virus replication. J. Virol. 40: 241-247.
10. Conway, J. E., et al. (1999). High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type 1 vector expressing AAV-2 rep and cap. Gene Ther. 6: 986-993.
11. Roizman, B. (1996). The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors. Proc. Natl. Acad Sci. USA 93: 11307-11312.
12. Marconi, P., et al. (1996). Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc. Natl. Acad. Sci. USA 93: 11319-11320.
13. Li, J., Samulski, R. J., and Xiao, X. (1997). Role for highly regulated rep gene expression in adeno-associated virus vector production. J. Virol. 71: 5236-5243.
14. McCarthy, A. M., McMahan, L., and Schaffer, P. A. (1989). Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol. 63: 18-27.
15. Halbert, C. L, Rutledge, E. A., Allen, J. M., Russell, D. W., and Miller, A. D. (2000). Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74: 1524-1532.
16. Xiao, W., et al. (1999). Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73: 3994-4003.
17. Rutledge, E. A., Halbert, C. L., and Russell, D. W. (1998). Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J. Viral. 72: 309-319.
18. Clark, K. R., Voulgaropoulou, F., Fraley, D. M., and Johnson, P. R. (1995). Cell lines for the production of recombinant adeno-associated virus. Hum. Gene Ther. 6: 1329-1341.
19. Gao, G., et al. (1998). High-titer adeno-associated viral vectors from a rep/cap cell line and hybrid shuttle virus. Hum. Gene Ther. 9: 2353-2362.
20. Liu, X. L., Clark, K. R., and Johnson, P. R. (1999). Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus. Gene Ther. 6: 293-299.
21. Zhang, X., and Li, C. Y. (2001). Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach. Mol. Ther. 3: 787-792, doi:10.1006/mthe.2001.0306.
22. Weindler, F. W., and Heilbronn, R. (1991). A subset of herpes simplex virus replication genes provides helper functions for productive adeno-associated virus replication. J. Virol. 65: 2476-2483.
23. Knipe, D. M. (1989). The role of viral and cellular nuclear proteins in herpes simplex virus replication. Adv. Virus Res. 37: 85-123.
24. King, J. A, Dubielzig, R., Grimm, D., and Kleinschmidt, J. A. (2001). DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. EMBO J. 20: 3282-3291.
25. McKnight, S. L., and Gavis, E. R. (1980). Expression of the herpes thymidine kinase gene in Xenopus laevis oocytes: an assay for the study of deletion mutants constructed in vitro. Nucleic Acids Res. 8: 59 31-5948.
26. Chiorini, J. A, Kim, F., Yang, L., and Kotin, R. M. (1999). Cloning and characterization of adeno-associated virus type 5. J. Virol. 73:1309-1319.
27. Gilead, Z., et al. (1976). Immunological identification of two adenovirus 2-induced early Proteins possibly involved in cell transformation. Nature 264: 263-266.